Portrait of Graves, Garret

Graves, Garret

U.S. Representative LA-6 Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
12
Buys / sells
58% / 42%
Last trade
Jan 19, 2024
Last filing
Feb 15, 2024

Latest disclosed trades

Latest 10 of 12
Ticker Type Traded
COIN Sell Jan 19, 2024
COIN Buy Sep 30, 2022
ABNB Buy Apr 13, 2021
AMZN Buy Apr 12, 2021
C Sell Feb 17, 2021
DDD Sell Jan 27, 2021
PSTH Buy Dec 29, 2020
GOLD Buy Dec 28, 2020
CRNC Sell Jun 29, 2020
NUAN Sell Jun 29, 2020

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Graves, Garret stock trade activity

FilingIQ has indexed 12 congressional stock trade disclosures for Graves, Garret. The most recent disclosed transaction is dated Jan 19, 2024.

Across the full history, 7 purchases and 5 sales have been disclosed under the STOCK Act.

Top tickers traded by Graves, Garret

Frequently asked

How many stock trades has Graves, Garret disclosed?
FilingIQ tracks 12 Periodic Transaction Report disclosures for Graves, Garret, with the most recent dated Jan 19, 2024. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Graves, Garret a net buyer or net seller?
Across the disclosed trade history, 7 (58%) were purchases and 5 (42%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Graves, Garret come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.